Skip to main content

Evoke Pharma Inc

EVOKDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001403708

Evoke Pharma Inc was delisted in 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
15
Q3 2025, +5 vs. previous quarter
13F value
$2.94M
Reported value at the end of Q3 2025
Superinvestors holding
0
At the end of Q3 2025

Superinvestors holding EVOK, Q3 2025

Go to the superinvestors tab

No superinvestor reported holding EVOK at the end of Q3 2025.

Latest insider trades

Open-market purchases and sales by Evoke Pharma Inc insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 7, 2025 (view filing)Nov 61 dayKlein Roger M.10% OwnerSSale−9.00K$10.66−$95.9K−6.7%125.0K after2 lots
Jan 30, 2025 (view filing)6:39 PM ETJan 282 daysNantahala Capital Management, LLC and 2 others10% OwnerSSale−41$4.39−$179.870.0%148.2K after

Top 10 13F holders, Q3 2025

The largest institutional positions in Evoke Pharma Inc at the end of Q3 2025; share changes are against Q2 2025.

See all 15 holders
Institutions holding EVOK in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Morgan Stanley159,358$792.0K0.00%+159,294+248,896.9%Added
Nantahala Capital Management, LLC148,153$736.3K0.05%00.0%Unchanged
Bleichroeder LP146,395$727.6K0.14%+77,645+112.9%Added
National Wealth Management Group, LLC80,130$398.2K0.15%+80,130New
DRW Securities, LLC23,742$118.0K0.01%+23,742New
Vanguard Group Inc18,759$93.2K0.00%+18,759New
Two Sigma Securities, LLC10,437$51.9K0.01%+10,437New
Advisor Group Holdings, Inc.3,010$16.4K0.00%+3,010New
Northwestern Mutual Wealth Management Co272$1.35K0.00%+272New
Royal Bank of Canada190$1.00K0.00%+190New